Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative Sunitinib in Operable Breast Cancer
NCT00482755Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in breast cancer, sponsored by Canadian Cancer Trials Group. Primary endpoint: Feasibility of neoadjuvant sunitinib. Started Apr 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00482755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482755.